All News #Library
Rare Diseases
Latus Bio Secures IND Clearance, Key Designations for LTS-101
02 Dec 2025 //
BUSINESSWIRE
Pilatus Biosciences Secures FDA Orphan Drug Designation for PLT012
10 Dec 2024 //
PR NEWSWIRE

Market Place
Sourcing Support